why choose us

First received: March 14, 2023

Clinical Trial: A Study of DP303c in Patients With HER2-positive Advanced Solid Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: HER2-positive Advanced Solid Tumors

Study Type: INTERVENTIONAL


Official Title: A Multi-center, Single-arm, Phase ? Study of DP303c in Patients With HER2-positive Advanced Solid Tumors

Brief Summary: This is a study of DP303c in patients with HER2-positive advanced solid tumors.

Read more